Latest News

Constellation Brands (STZ) is back in focus after third quarter results topped expectations even as sales and profits softened, with management leaning on pricing, cost savings, dividends, and buybacks to steady the story. See our latest analysis for Constellation Brands. The latest results and capital return updates come after a mixed stretch for investors, with a 90 day share price return of 10.27% and an 8.49% year to date share price gain set against a 1 year total shareholder return of...

Why Waste Connections stock is drawing fresh attention Waste Connections (WCN) is back on investors’ radar after recent share price weakness, with the stock showing negative returns over the past week, month, past 3 months and year despite positive multi year performance. See our latest analysis for Waste Connections. The recent 6.5% 7 day share price decline and 6.4% year to date share price return have taken some momentum out of Waste Connections, even though the 5 year total shareholder...

Astena Holdings (TSE:8095) closed out FY 2025 with fourth quarter revenue of ¥17,267 million and basic EPS of ¥13.68, alongside net income of ¥552 million, providing a clear snapshot of where the business stands today. Over the past six reported quarters, revenue has ranged from ¥13,986 million to ¥17,267 million, while quarterly basic EPS has moved between a loss of ¥91.06 and a profit of ¥19.40 per share, giving investors a concrete view of how profitability has shifted through the period...

South32 Limited recently presented at the Future Minerals Forum 2026 at the King Abdul Aziz International Conference Center in Riyadh, with CEO Graham Kerr addressing attendees. This high-profile industry platform offered South32 an opportunity to highlight its positioning in future-facing metals and its response to global decarbonization themes. We’ll now examine how South32’s high-profile Future Minerals Forum appearance, led by CEO Graham Kerr, may influence its investment...

Insiders who purchased AU$8.99m worth of Terramin Australia Limited ( ASX:TZN ) shares over the past year recouped some...

Earlier this month, The Trade Desk announced that major publishers including AccuWeather, BuzzFeed, the Guardian, Hearst, Newsweek, People Inc., and Ziff Davis are backing its new OpenAds auction environment, which aims to give publishers and sellers a more direct, transparent way to run digital ad auctions. This broad publisher support highlights growing industry demand for higher-integrity programmatic auctions and positions OpenAds as a potential benchmark for transparency across the...

Lithium Americas has attracted renewed attention as investors react to progress at its Thacker Pass project, evolving supply chain plans in North and South America, and recent updates on partnerships and regulatory trends, all set against ongoing operational losses reported prior to today, 14 January 2026. An important angle is how Thacker Pass and related collaborations position Lithium Americas at the center of U.S. efforts to secure domestic lithium supplies amid shifting geopolitical and...

Procter & Gamble (PG) is back in focus after recent share moves, as investors weigh its consumer staples profile against mixed return figures over different time frames and a current share price of $144.24. See our latest analysis for Procter & Gamble. Recent trading has been steady rather than sharp, with a 7 day share price return of 3.1% on top of a year to date share price return of 1.7%. However, the 1 year total shareholder return of 7.3% and 5 year total shareholder return of 22.4%...

In early January 2026, Intellia Therapeutics reported a fatal safety event and Grade 4 liver abnormalities in its Phase 3 MAGNITUDE ATTR-CM trial, prompting the FDA to place both MAGNITUDE and MAGNITUDE-2 studies on clinical hold while the company works with regulators on a path forward for nexiguran ziclumeran (nex-z). This setback for Intellia’s lead in vivo CRISPR program sharply elevates its regulatory and development risk profile, particularly given the company’s reliance on a...

SS Innovations International recently issued preliminary, unaudited results indicating fourth-quarter 2025 revenue of about US$15.0 million and full-year 2025 revenue of about US$43.0 million, both sharply higher than 2024 levels and driven by increased SSi Mantra surgical robot sales and installations. Alongside this growth, the company expanded its leadership bench by appointing veteran executive Milan Rao as both Chief Financial Officer and Global Chief Operating Officer, underscoring its...

If you are wondering whether Teva Pharmaceutical Industries is still reasonably priced after its recent run, this article will walk through what the current share price might be implying about value. Teva's stock last closed at US$32.47, with returns of 1.1% over 7 days, 9.0% over 30 days, 4.9% year to date, 54.8% over 1 year and 194.6% over 3 years. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on Teva as investors...

Operational results at Tocantinzinho and why they matter for shareholders G Mining Ventures (TSX:GMIN) has drawn fresh attention after releasing preliminary fourth quarter and full year 2025 operating results for its Tocantinzinho Gold Mine in Pará, Brazil, marking its first full year of commercial production. The company reported fourth quarter gold output of 47,346 ounces, with ore tonnage mined of 1,725,000 tonnes and 1,077,000 tonnes processed. For the full year, gold production reached...

LVMH Moët Hennessy - Louis Vuitton Société Européenne (ENXTPA:MC) is back in focus after recent trading left the share price near €637.90, inviting investors to reassess the luxury group’s longer term return profile. See our latest analysis for LVMH Moët Hennessy - Louis Vuitton Société Européenne. Recent trading has been slightly softer, with a 1 day share price return of 1.35% and a 7 day share price return of 1.37%. The 1 year total shareholder return of 2.51% contrasts with a 3 year total...

Ultragenyx Pharmaceutical (RARE) is back in focus after reporting preliminary 2025 revenue guidance of US$672 million to US$674 million, which is above its prior range, alongside completing an FDA BLA submission for gene therapy candidate DTX401. See our latest analysis for Ultragenyx Pharmaceutical. The raised 2025 revenue guidance and DTX401 BLA completion come after a volatile period, with a 7 day share price return of 6.97% but a 30 day share price return of a 33.45% decline, and a 1 year...

Intel (INTC) is back in the spotlight after a cluster of analyst upgrades tied to surging AI server CPU demand, tighter 2026 capacity, progress on its 18A foundry ramp, and new Core Ultra Series 3 AI PC chips. See our latest analysis for Intel. Those AI driven headlines have played out in the share price too, with a 27.29% 90 day share price return, a 20.09% year to date share price return and a very large 1 year total shareholder return, suggesting momentum has been building as investors...

Context for Navitas Petroleum Limited Partnership (TASE:NVPT) Navitas Petroleum Limited Partnership (TASE:NVPT) has drawn investor attention recently as its unit price and return profile show mixed moves over the month and past 3 months, alongside a materially positive 1 year total return. The partnership focuses on exploration and production of oil and natural gas across North and South America, with projects such as Shenandoah, Sea Lion, Buckskin, Monument and several U.S. fields forming...

For investors considering whether Sarepta Therapeutics is a potential bargain or a value trap at its current share price, this article walks through what the numbers say about the stock. The share price recently closed at US$21.46, with returns of a 4.0% decline over 7 days, a 0.3% decline over 30 days, a 0.7% gain year to date, and declines of 81.9% over 1 year, 83.5% over 3 years, and 77.8% over 5 years. Recent coverage of Sarepta has focused on how the company fits into the high risk,...

In early January 2026, Digi Power X Inc. announced a non-binding letter of intent with Omnis Pleasants LLC to explore up to 1.3 GW of power access, a land lease of up to 200 acres, and potential equity alignment tied to the Pleasants Power Station in West Virginia for AI and high-performance computing infrastructure. The proposed framework could give Digi Power X both the physical footprint and a pathway to a more than 10% ownership stake in a large power asset, aligning data center...

China Jinmao Holdings Group (SEHK:817) has released unaudited contracted sales figures for December and for the full year 2025, giving investors a fresh data point on project sales momentum and capital deployment. See our latest analysis for China Jinmao Holdings Group. The new contracted sales update lands after a mixed year for the stock, with a 1 month share price return of 6.56% and a 1 year total shareholder return of 50.53%. However, the 3 year and 5 year total shareholder returns...

Why Lennox International Is On Investors’ Radar Today Lennox International (LII) has caught attention after recent share performance, with the stock showing mixed returns across different periods and a last close of US$531 that some investors are reassessing. See our latest analysis for Lennox International. Recent price moves at Lennox International have been relatively steady, with a 4.99% 1 month share price return and a 6.43% year to date share price return. The 1 year total shareholder...

In recent weeks, Coinbase Global has outlined an ambitious push into tokenized equities, expanded institutional crypto services with Standard Chartered, and prepared a 31-product derivatives platform offering up to 10x leverage on major cryptocurrencies, while simultaneously clashing with U.S. lawmakers over potential limits on stablecoin rewards. This combination of innovation in tokenization and derivatives, deeper institutional integration, and regulatory tension around a key revenue...

Key Insights Significant control over Centuria Capital Group by individual investors implies that the general public...

Alcidion Group Limited ( ASX:ALC ) shares have continued their recent momentum with a 33% gain in the last month alone...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...